Apr 22 |
10 Best Performing Biotech ETFs in 2024
|
Apr 16 |
Sentia Medical Sciences and Neurocrine Biosciences extend research collaboration
|
Apr 16 |
Sentia Medical Sciences and Neurocrine Biosciences Extend Research Collaboration to Discover Novel CRF Peptides
|
Apr 10 |
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2024 Financial Results
|
Apr 9 |
11 Best Biotech ETFs To Buy
|
Apr 3 |
Is Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Recent Performance Tethered To Its Attractive Financial Prospects?
|
Apr 3 |
Neurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive Disorder
|
Mar 28 |
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1065890, a Second-Generation VMAT2 Inhibitor, in Healthy Adults
|
Mar 23 |
S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind
|
Mar 22 |
Dow Jones Futures: Apple Sour, But These 11 Stocks Flash Buy Signals; FedEx Soars Late
|